PGP and neoplasm: The notion that 4A6 is a bona fide P-gp and MRP1 substrate may on the one hand compromise some of its activity against tumor cell expressing this drug efflux transporter, but on the other hand it may underlie a different, possibly more favorable toxicity profile than BTZ.